View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
checkbox unchecked Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
checkbox checked Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Curet Myriam
(Last) (First) (Middle)
1020 KIFER ROAD
(Street)
SUNNYVALE CA 94086
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
checkbox checked Officer (give title below) Other (specify below)
EVP & Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
checkbox checked Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/12/2024 M(1) 2,257 A $177.9867 2,555 D
Common Stock 11/12/2024 S(1) 2,257 D $535.9569(2) 298 D
Common Stock 11/12/2024 M(1) 5,000 A $182.8333 5,298 D
Common Stock 11/12/2024 S(1) 5,000 D $535.9569(2) 298 D
Common Stock 11/12/2024 M(1) 2,199 A $229.39 2,497 D
Common Stock 11/12/2024 S(1) 2,199 D $535.9569(2) 298 D
Common Stock 11/12/2024 M(1) 4,010 A $208.9 4,308 D
Common Stock 11/12/2024 S(1) 4,010 D $535.9569(2) 298 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $177.9867 11/12/2024 M(1) 2,257 (3) 02/28/2030 Common Stock 2,257 $0.0 0 D
Non-Qualified Stock Option (right to buy) $182.8333 11/12/2024 M(1) 5,000 (3) 02/15/2029 Common Stock 5,000 $0.0 0 D
Non-Qualified Stock Option (right to buy) $208.9 11/12/2024 M(1) 4,010 (4) 08/28/2029 Common Stock 4,010 $0.0 2,005 D
Non-Qualified Stock Option (right to buy) $229.39 11/12/2024 M(1) 2,199 (5) 02/27/2030 Common Stock 2,199 $0.0 2,829 D
Explanation of Responses:
1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.
2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
4. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
5. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
By: Donna Spinola For: Curet, Myriam 11/13/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
Know all by these present that the undersigned hereby
authorizes Donna Spinola, Stephanie Lim-Ignacio, Thanh Nhan
Phan, and Cory Balliet of Intuitive Surgical, Inc. (the
"Company") and Mark Roeder and John Williams of Latham & Watkins
LLP, and each of them individually, to (i) execute for and on
behalf of the undersigned, in the undersigned's capacity as an
officer or director of the Company, Forms 3, 4, and 5, and
Notices of Proposed Sale of Securities Pursuant to Rule 144
("Form 144"), in accordance with the requirements of Rule 144
under the Securities Act of 1933, as amended (the "Securities
Act"), and other forms as may be required, and any amendments
thereto, and cause such forms to be filed with the U.S.
Securities and Exchange Commission (the "SEC") pursuant to
Section 16(a) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and Rule 144 under the Securities Act,
relating to the undersigned's ownership of and transactions in
securities of the Company and (ii) execute for and on behalf of
the undersigned in the undersigned's name, and submit to the
SEC, a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain and/or regenerate
codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the
Exchange Act, Rule 144 of the Securities Act or any rule or
regulation of the SEC. The undersigned hereby grants to each
such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary, or
proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and
confirming all that such attorneys-in-fact, or such attorneys-
in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights
and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act or Rule 144 under the
Securities Act.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms
3, 4, and 5 and Form 144 with respect to the undersigned's
holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this day of July 25,
2024.
/s/ Myriam Curet
MYRIAM CURET